DR. MICHAEL J CLARE-SALZLER, MD
Osteopathic Medicine at Archer Rd, Gainesville, FL
License number
Florida ME75441
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
2
1600 SW Archer Rd, Gainesville, FL 32610
PO Box 918025, Orlando, FL 32891
PO Box 918025, Orlando, FL 32891
Phone
(352) 392-9885
(352) 392-5393 (Fax)
(352) 392-5393 (Fax)
Personal information
See more information about MICHAEL J CLARE-SALZLER at radaris.comName
Address
Phone
8104 42Nd Ave, Gainesville, FL 32608
8104 42Nd St, Gainesville, FL 32608
Professional information
See more information about MICHAEL J CLARE-SALZLER at trustoria.com
Prof. At U. Of Florida
Prof. At U. Of Florida
Position:
prof. at U. of Florida
Location:
Gainesville, Florida Area
Industry:
Biotechnology
Work:
U. of Florida
-
prof.
Dr. Michael J Clare-Salzler, Gainesville FL - MD (Doctor of Medicine)
Dr. Michael J Clare-Salzler, Gainesville FL - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology
Address:
2000 SW Archer Rd SUITE M648, Gainesville 32608
(352) 265-0139 (Phone), (352) 733-4268 (Fax)
UNIVERSITY OF FLORIDA INTERNAL
2000 SW Archer Rd SUITE 1901, Gainesville 32608
(352) 265-0139 (Phone), (352) 265-0344 (Fax)
UNIVERSITY OF FLORIDA
1600 SW Archer Rd, Gainesville 32610
(352) 265-0111 (Phone), (352) 392-3618 (Fax)
(352) 265-0139 (Phone), (352) 733-4268 (Fax)
UNIVERSITY OF FLORIDA INTERNAL
2000 SW Archer Rd SUITE 1901, Gainesville 32608
(352) 265-0139 (Phone), (352) 265-0344 (Fax)
UNIVERSITY OF FLORIDA
1600 SW Archer Rd, Gainesville 32610
(352) 265-0111 (Phone), (352) 392-3618 (Fax)
Languages:
English
Education:
Medical School
State University of New York At Buffalo
State University of New York At Buffalo
Michael J Clare-Salzler, Gainesville FL
Michael J Clare-Salzler, Gainesville FL
Specialties:
Endocrinologist
Address:
1600 Sw Archer Rd, Gainesville, FL 32610
Cox-2 Mediated Altered Prostaglandin Balance In Diabetes Complications
Cox-2 Mediated Altered Prostaglandin Balance In Diabetes Complications
US Patent:
2004012, Jun 24, 2004
Filed:
Aug 29, 2003
Appl. No.:
10/652216
Inventors:
Vikas Dharnidharka - Gainesville FL, US
Michael Clare-Salzler - Gainesville FL, US
Michael Clare-Salzler - Gainesville FL, US
International Classification:
G01N033/543
US Classification:
436/518000
Abstract:
The subject invention concerns novel methods for determining an individual's risk of developing diabetes-related complications. An embodiment provides determining at the onset or prior to the onset of Type I diabetes those individuals with a high risk of developing diabetes-related complications. The subject invention also concerns therapeutic methods for inhibiting and/or preventing the development of diabetes-related complications prior to or at the onset of T1D.
Methods And Compositions For Expressing A Nucleic Acid In A Dendritic Cell
Methods And Compositions For Expressing A Nucleic Acid In A Dendritic Cell
US Patent:
2004007, Apr 15, 2004
Filed:
Apr 30, 2003
Appl. No.:
10/427165
Inventors:
Karl Womer - Gainesville FL, US
Sihong Song - Gainesville FL, US
Terence Flotte - Alachua FL, US
Scott Loiler - Gainesville FL, US
Mark Atkinson - Gainesville FL, US
Michael Clare-Salzler - Gainesville FL, US
Jude Samulski - Chapel Hill NC, US
Sihong Song - Gainesville FL, US
Terence Flotte - Alachua FL, US
Scott Loiler - Gainesville FL, US
Mark Atkinson - Gainesville FL, US
Michael Clare-Salzler - Gainesville FL, US
Jude Samulski - Chapel Hill NC, US
International Classification:
A61K048/00, C12N015/861
US Classification:
435/456000, 424/093200
Abstract:
Recombinant adeno-associated virus (rAAV) virions having a serotype 1 capsid protein are effective for transferring heterologous nucleic acids into DC.
Materials And Methods For Detection And Treatment Of Immune System Dysfunctions
Materials And Methods For Detection And Treatment Of Immune System Dysfunctions
US Patent:
6218133, Apr 17, 2001
Filed:
May 28, 1999
Appl. No.:
9/322628
Inventors:
Michael Clare-Salzler - Gainesville FL
Assignee:
University of Florida - Gainesville FL
International Classification:
C12Q 126, C12Q 168, G01N 33564, G01N 33573, G01N 3388
US Classification:
435 724
Abstract:
The subject invention concerns novel materials and methods for the treatment and/or prevention of autoimmune disease. In a specific embodiment, elevated production of prostaglandin synthase-2 (PGS-2) is correlated with autoimmune dysfunction.
Materials And Methods For Detection And Treatment Of Immune System Dysfunctions
Materials And Methods For Detection And Treatment Of Immune System Dysfunctions
US Patent:
6953578, Oct 11, 2005
Filed:
Mar 29, 2001
Appl. No.:
09/821435
Inventors:
Michael Clare-Salzler - Gainesville FL, US
Assignee:
University of Florida Research Foundation, Inc. - Gainesville FL
International Classification:
A61K039/00, A61K045/00
US Classification:
4241841, 424 851, 424810, 514 2, 514866, 514885
Abstract:
The subject invention concerns novel materials and methods for the treatment and/or prevention of autoimmune disease. In a specific embodiment, elevated production of prostaglandin synthase-2 (PGS-2) is correlated with autoimmune dysfunction.
Materials And Methods For Detection And Treatment Of Immune System Dysfunctions
Materials And Methods For Detection And Treatment Of Immune System Dysfunctions
US Patent:
5939069, Aug 17, 1999
Filed:
Aug 23, 1996
Appl. No.:
8/701928
Inventors:
Michael Clare-Salzler - Gainesville FL
Assignee:
University of Florida - Gainesville FL
International Classification:
A61K 3118, A61K 31405, A61K 3900
US Classification:
4241841
Abstract:
The subject invention concerns novel materials and methods for the treatment and/or prevention of autoimmune disease. In a specific embodiment, elevated production of prostaglandin synthase-2 (PGS-2) is correlated with autoimmune dysfunction.
Materials And Methods For Detection And Treatment Of Immune System Dysfunctions
Materials And Methods For Detection And Treatment Of Immune System Dysfunctions
US Patent:
6168792, Jan 2, 2001
Filed:
Aug 22, 1997
Appl. No.:
8/916586
Inventors:
Michael Clare-Salzler - Gainesville FL
Assignee:
University of Florida - Gainesville FL
International Classification:
A61K 3118, A61K 31405, A61K 3900
US Classification:
4241841
Abstract:
The subject invention concerns novel materials and methods for the treatment and/or prevention of autoimmune disease. In a specific embodiment, elevated production of prostaglandin synthase-2 (PGS-2) is correlated with autoimmune dysfunction.
Peptides Derived From Glutamic Acid Decarboxylase
Peptides Derived From Glutamic Acid Decarboxylase
US Patent:
5674978, Oct 7, 1997
Filed:
Sep 17, 1993
Appl. No.:
8/123859
Inventors:
Allan J. Tobin - Los Angeles CA
Mark G. Erlander - Tarzana CA
Daniel L. Kaufman - Santa Monica CA
Michael J. Clare-Salzler - Gainesville FL
Mark G. Erlander - Tarzana CA
Daniel L. Kaufman - Santa Monica CA
Michael J. Clare-Salzler - Gainesville FL
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07K 14435, C07K 700, C12N 988
US Classification:
530326
Abstract:
Isolated polypeptides useful in ameliorating GAD-associated autoimmune disease as well as diagnostic and therapeutic methods of using the peptides are disclosed.